Edwards Lifesciences Corporation (EW)
- Previous Close
87.42 - Open
87.63 - Bid 87.62 x 900
- Ask 87.66 x 1100
- Day's Range
87.37 - 88.09 - 52 Week Range
60.57 - 96.12 - Volume
438,830 - Avg. Volume
3,421,088 - Market Cap (intraday)
52.809B - Beta (5Y Monthly) 1.10
- PE Ratio (TTM)
37.77 - EPS (TTM)
2.32 - Earnings Date Jul 24, 2024 - Jul 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
95.52
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
www.edwards.comRecent News: EW
Performance Overview: EW
Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EW
Valuation Measures
Market Cap
52.68B
Enterprise Value
51.68B
Trailing P/E
37.68
Forward P/E
31.85
PEG Ratio (5yr expected)
3.51
Price/Sales (ttm)
8.65
Price/Book (mrq)
7.40
Enterprise Value/Revenue
8.41
Enterprise Value/EBITDA
29.21
Financial Highlights
Profitability and Income Statement
Profit Margin
23.01%
Return on Assets (ttm)
12.05%
Return on Equity (ttm)
21.28%
Revenue (ttm)
6.14B
Net Income Avi to Common (ttm)
1.41B
Diluted EPS (ttm)
2.32
Balance Sheet and Cash Flow
Total Cash (mrq)
1.7B
Total Debt/Equity (mrq)
9.73%
Levered Free Cash Flow (ttm)
671.94M
Research Analysis: EW
Company Insights: EW
EW does not have Company Insights